Thus, Yvonne J.
Eldering, Eric
Kater, Arnon P.
Spaargaren, Marcel https://orcid.org/0000-0002-3135-5109
Funding for this research was provided by:
KWF Kankerbestrijding (UVA 2015-7873, UVA 2015-7873)
Article History
Received: 15 April 2022
Revised: 7 June 2022
Accepted: 8 June 2022
First Online: 20 June 2022
Competing interests
: APK and EE received research funding from Genentech, Janssen, Astra Zeneca, BMS, and Roche. The remaining authors declare that they have no competing financial interests.